Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
for B-cell Non-Hodgkin Lymphoma (B-NHL)
4 locations incl. Chicago
Sponsor: Cellectis S.A.
Sex: All·Age: 18 - 80
Code: NCT05607420·Phase 1, Phase 2·Recruiting·Listed Nov 2022
Sarah Cannon - St. David South Austin Medical Center
Clinical research site in Austin, Texas
Part of Sarah Cannon Research Institute
As of July 2026, 1 paid clinical trial is recruiting at Sarah Cannon - St. David South Austin Medical Center in Austin, Texas. Active studies at this site focus on B-cell Non-Hodgkin Lymphoma (B-NHL) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Sarah Cannon - St. David South Austin Medical Center (1)
More research sites in Austin
- Dell Children's Medical Center of Central Texas (35 trials)
- University of Texas at Austin (21 trials)
- The University of Texas at Austin (19 trials)
- FutureSearch Trials of Neurology (14 trials)
- GSK Investigational Site (11 trials)
- Dell Children's Medical Center (11 trials)
- Texas Cardiac Arrhythmia Research Foundation (11 trials)
- Austin Heart (10 trials)
- NEXT Austin (10 trials)
- Texas Oncology - Central South (9 trials)